Old and New Drug Targets in Diabetic Retinopathy: From Biochemical Changes to Inflammation and Neurodegeneration

Current Drug Target -CNS & Neurological Disorders
doi 10.2174/1568007054546162
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Cellular Signaling and Potential New Treatment Targets in Diabetic Retinopathy

Experimental Diabetes Research
2007English

Neurodegeneration in Non‐proliferative Diabetic Retinopathy: New Biomarkers and Their Relation to Vasculopathy and Visual Function

Acta Ophthalmologica
MedicineOphthalmology
2018English

Diabetic Retinopathy: Recent Advances Towards Understanding Neurodegeneration and Vision Loss

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2015English

New Drug Targets in Inflammation: Efforts to Expand the Anti-Inflammatory Armoury

British Journal of Pharmacology
Pharmacology
2009English

Neurodegeneration in the Pathogenesis of Diabetic Retinopathy: Molecular Mechanisms and Therapeutic Implications

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2013English

Retinal Neurodegeneration Exists in Type 1 Diabetes Prior Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Fundus Autofluorescence Changes in Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Retinal Neurodegeneration in Patients With Type 2 Diabetes Mellitus Without Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

New Therapeutic Approaches in Diabetic Retinopathy

Review of Diabetic Studies
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy